The latest developments from Sermo.Back to Press Releases
Sermo in the News
Sermo Taps Tim Davenport as CEO
March 28, 2012
Largest Online Doctor Network Launches iConsult App for iPhone
August 3, 2011
Physicians More Skeptical of Electronic Medical Records
February 23, 2011
For Immediate Release
WorldOne Interactive and Treato Partner to Enhance MedLIVE FastResponse Market Intelligence Tool
WorldOne integrates Treato’s Patient Perception Reports for Real-time Patient Intelligence
New York and Yehud, Israel - August 14, 2012 - WorldOne (www.worldone.com), the global leader in healthcare insights and intelligence and Treato (www.treato.com), a unique source of patient intelligence based on online discussions, today announced a strategic partnership to integrate Treato's innovative patient perception reports into the MedLIVE FastResponse market intelligence platform.
This past year WorldOne Interactive, the global engagement division of WorldOne, Inc., successfully launched MedLIVE (www.MedLIVE), a self-service portal that enables clients to send quick PULSE surveys to targeted segments of WorldOne's Global Networked Community of 1.8 million healthcare professionals (including over 1 million verified physicians across 80 countries). Media agencies, advertising agencies, and pharmaceutical manufacturers utilize MedLIVE to derive data and insights from global healthcare professionals within hours to help make critical business decisions and shape brand strategies.
With the addition of Treato, clients will be able to complement their physician and healthcare professional PULSES with a patient perception report, offering a lens into consumer behaviors and the client's competitive position. At a single click, Treato's brand perception tool aggregates real-time patient thoughts and attitudes into an insightful and user-friendly graphical report covering topics such as patient-reported drug use, drug switching and positive and negative drug experiences.
Treato automatically distills relevant meaning from patient-written health experiences on social media sites. Using patent-pending Natural Language Processing (NLP) algorithms and proprietary patient language dictionaries, Treato explores what patients have written about their medications and conditions in real-time and processes massive amounts of Web content into the collective voice of the patient. To date, Treato has analyzed over 1.1 billion patient posts, covering 24,000 conditions and medications.
“Treato is a perfect complement to MedLIVE. We built MedLIVE to be the fastest, most relevant and cost effective market intelligence and insights platform available to healthcare stakeholders. Tapping into online patient discussions will provide a more holistic understanding of physician decision making as well as patient attitudes and perceptions,” said Peter Kirk, CEO of WorldOne.
“We are excited to join forces with WorldOne in its advanced market intelligence offering to the healthcare community; The capabilities offered through MedLIVE for understanding attitudes among physicians coupled with Treato's patient insights create a powerful and comprehensive viewpoint,” said Ido Hadari, President of Treato. “Patients' actions and opinions are becoming a crucial factor in the healthcare and life science industry, and this partnership strengthens our vision of delivering the voice of the patient to key healthcare stakeholders."
WorldOne is the largest healthcare data collection company in the world serving the market research industry for over a decade. Headquartered in New York with 18 regional offices across North America, South America, Europe and Asia-Pacific, WorldOne offers clients online and offline access to medical professionals in over 80 countries through a range of differentiated products and services. WorldOne's global network includes over 1.8 million fully verified healthcare professionals, who in 2011 completed nearly half a million online surveys, answering over 20 million questions.
Treato is a new platform of patient intelligence based on online discussions about real life experiences. Since its launch in 2011, over a billion patient discussions from forums and blogs have been analyzed, generating the collective patient voice for the very first time. The company is privately held and backed by Reed Elsevier Ventures and a group of private investors. For more information, visit http://treato.com.
Want to do business with Sermo? Get in Touch